Genentech
Fda Approves Rituxan
Published in Hospital Business Week, August 10th, 2008
THIS IS A MULTIVU SPECIAL REPORT BROUGHT TO YOU BY GENENTECH. RITUXAN, THE FIRST AND CURRENTLY ONLY C-D-20-POSITIVE B-CELL TARGETED BIOLOGIC FOR RHEUMATOID ARTHRITIS, OR R-A, IS F-D-A APPROVED IN COMBINATION WITH METHOTREXATE TO SLOW THE PROGRESSION OF STRUCTURAL DAMAGE IN ADULT PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE R-A WHO HAVE HAD AN INADEQUATE RESPONSE TO ONE OR MORE TUMOR NECROSIS FACTOR INHIBITORS.
RITUXAN IS PART OF A CLASS OF DRUGS CALLED BIOLOGICS, WHICH ARE SHOWING GREAT PROMISE IN TREATING DISEASES LIKE R-A.
DOCTOR PHILIP MEASE, A LEADING RHEUMATOLOGIST AT THE SWEDISH HOSPITAL IN SEATTLE.
"Progression of structural...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Adverse Drug Reactions
Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs - Advocates for Youth
Giving 'Faith Based' a Bad Name - Aegis Health Group
Norton Healthcare Inc. Partners With Aegis Health Group to Bring Health- Management Program to Area Employers - Aethon Inc.
Aethon, Inc. Names New Chief Financial Officer - Air Products
Air Products Announces Plans to Sell Its U.S. Healthcare Business; Will Record Impairment Charge for Fiscal Third Quarter - Alexza Pharmaceuticals, Inc.
Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 Staccato Loxapine - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
